Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Inhaled Versus Intravenous Milrinone for Patients Undergoing Mitral Valve Replacement Surgery

NCT05838846 is registered in ClinicalTrials.gov with Menoufia University as lead sponsor.

NCT NCT05838846
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05838846 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Inhaled Versus Intravenous Milrinone for Patients Undergoing Mitral Valve Replacement Surgery
Lead sponsor
Menoufia University
Phase
Phase 2/3
Overall status
Completed
Start date
April 1, 2023
Completion date
January 1, 2025
Enrollment
60 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

inhaled milrinone, intravenous milrinone, mitral valve replacement, pulmonary hypertension